Newsletters
Document Overview
Best Practices: 2010 Life Science Manufacturing and Supply Chain IT Benchmark Guide
| Author: | Eric Newmark |
| Document # | HI223134 |
| Published | May, 2010 |
| Document Type | Best Practices |
| Number of Pages | 20 |
Overview
This IDC Health Insights study details IT spending expectations for the life science manufacturing and supply chain industry segment, which are currently projected to grow moderately during 2010.
Eric Newmark, research manager at IDC Health Insights, commented, "With the global recession now in the rear view mirror, life science companies are concentrating less on cost reduction and beginning to focus more strongly on top-line growth. Manufacturing and supply chain strategies are essential components for maintaining an informed, agile, low-cost enterprise, which are critical for enabling sustained long-term growth. As the industry consolidates in an effort to capitalize on cross-company synergies and overlapping overhead structures, several manufacturing and supply chain initiatives play a central role. This includes increased outsourcing and offshoring, reducing corporate liability and protecting brand equity (PAT, drug pedigree), and optimizing operational efficiency (via item-level serialization). Though widespread item-level visibility is still years away, companies realize that it holds significant promise for drastically improving supply chain visibility, reducing inventory levels, optimizing production planning, increasing chargeback and rebate accuracy, and reducing revenue leakage across the enterprise."
Life Science Business Systems Strategy
Insights: Health Industry, Pharma
Our records show that you do not have access to this document.
